Grifols Separates Subsidiary for Wall Street IPO

Grifols, a hemoderivatives company, is separating a subsidiary from its main structure to strengthen its autonomy before taking it public on Wall Street.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

la-vanguardiaSpanish47d ago

Grifols separa de su estructura la filial con la que prepara el salto a Wall Street

La compañía de hemoderivados quiere reforzar la autonomía de esta división antes de sacarla a bolsa

Read full article →

PERSPECTA

PERSPECTA

Grifols Separates Subsidiary for Wall Street IPO

Sources

Grifols separa de su estructura la filial con la que prepara el salto a Wall Street

Related Stories

Bulgaria Returns 11.6 Tons of Peppers to North Macedonia Due to Pesticides

Goldman Sachs to Acquire ETF Provider Neos in $2.3 Billion Deal

L3Harris CEO Chris Kubasik Ousted Over Unspecified Conduct

KBR Secures $60 Million NATO Contract for Missile Defense System

PERSPECTA